Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 5, 1999, Pages 529-535

  Beckett, C G ^a   Dell'Olio, D ^a   Shidrawi, R G ^a   Rosen Bronson, S ^b   Ciclitira, P J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coeliac disease; Gluten; Human small intestine; Interferon; Interleukin 1; Nitric oxide; Tumour necrosis factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUTEN; INTERLEUKIN 1; N(G) METHYLARGININE; NITRIC OXIDE; NITRITE; OVALBUMIN; PEPSIN A; PROTEIN; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CELL CULTURE; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE CELL; MALE; MICROSCOPY; PRIORITY JOURNAL; SMALL INTESTINE;

EID: 0033037031     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199905000-00011     Document Type: Article

References (38)

1. 1 Trier J, Browning T. Epithelial cell renewal in cultured duodenal biopsies in celiac sprue. N Engl J Med 1970; 283:1245-1250.
2. 2 Falchuk Z, Gebhard R, Sessons C, Strober W. An in vitro model of gluten sensitive enteropathy. J Clin Invest 1974; 53:487-500.
3. 3 Howdle P, Corazza G, Bullen A, Losowsky M. In vitro diagnosis of coeliac disease: an assessment. Gut 1981; 22:939-947.
4. 4 Howdle P, Corazza G, Bullen A, Losowsky M. Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histologic change. Gastroenterology 1981; 80:442-450.
5. 5 Fluge G, Aksnes L. Morphological and morphometric assessment of human duodenal biopsies maintained in organ culture. Scand J Gastroenterol 1981; 16:555.
6. 6 Sturgess R, Day P, Ellis H, Lundin K, Gjertsen H, Kontakou M, Ciclitira P. Wheat peptide challenge in coeliac disease. 1994; 343:758-761.
7. 7 Shidrawi R, Day P, Przemioslo R, Ellis H, Nelufer J, Ciclitira P. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol 1995; 30:758-763.
8. 8 Ferguson A, McClure J, MacDonald T, Holden R. Cell-mediated immunity to gliadin within the small intestinal mucosa in coeliac disease. Lancet 1975; 1:895-897.
9. 9 Howdle P, Bullen A, Losowsky M. Cell-mediated immunity to gluten within the small intestinal mucosa in coeliac disease. Gut 1982; 23:115-122.
10. 10 Maiuri L, Picarelli A, Boirivant M, Coletta S, Mazzilli MC, De Vincenzi M, et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996; 110:1368-1378.
11. 11 Lundin K, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, et al. Gliadin specific, HLA-DQ (a1*0501,b1*0201) restricted T cells isolated from the small intestinal mucosa of coeliac disease patients. J Exp Med 1993; 178:187-196.
12. 12 Nilsen E, Lundin K, Krajci P, Scott H, Sollid L, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon γ. Gut 1995; 37:766-776.
13. 13 Przemioslo R, Lundin K, Sollid L, Nelufer J, Ciclitira P. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon γ antibody. Gut 1995; 36:874-879.
14. 14 Kontakou M, Przemioslo R, Sturgess R, Limb GA, Ellis HJ, Day P, Ciclitira PJ. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut 1995; 37:52-57.
15. 15 Walker-Smith J, Guandalini S, Schmitz J, Schmerling D, Visakorpi J. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990; 65:909-911.
16. 16 Stuehr D, Marletta M. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82:7738-7742.
17. 17 Beckett C, Dell'Olio D, Nelufer J, Ciclitira P. Increased inducible nitric oxide synthase mRNA and protein in the small intestine of patients with untreated coeliac disease. Eur J Gastroenterol Hepatol 1999; in press.
18. 18 Steege J, Buuman W, Arends J, Forget P. Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab Invest 1997; 77(1):29-36.
19. 19 Middleton S, Shorthouse M, Hunter J. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341:465-466.
20. 20 Boughton-Smith N, Evans S, Hawkey C, Cole AT, Balsitis M, Whittle BJ, Moncada S. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342:338-340.
21. 21 Boughton-Smith N. Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease. J Roy Soc Med 1994; 87:312-314.
22. 22 Rachmilewitz D, Karmeli F, Okon E, Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995; 37:247-255.
23. 23 Salzman AL. Nitric oxide and the gut. New Horizons 1995; 3: 33-45.
24. 24 Schmidt H, Lohman S, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993; 1178:153-175.
25. 25 Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenic factor in autoimmunity. Immunol Today 1992; 13(5):157-160.
26. 26 Ankarcrona M, Dypbukt J, Brune B, Nicotera P. Interleukin-1 beta induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 1994; 213(1):172-177.
27. 27 Garside P, Hutton A, Severn A, Liew F, Mowat A. Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur J Immunol 1992; 22:2141-2145.
28. 28 Przemioslo R, Wright N, Elia G, Ciclitira P. Analysis of crypt cell proliferation in coeliac disease using MI-B1 antibody shows an increase in growth fraction. Gut 1995; 36:22-27.
29. 29 Moss S, Attia L, Scoles J, Walters J, Holt P. Increased small bowel epithelial apoptosis in coeliac disease. Gut 1996; 39:811-817.
30. 30 Schmidt H, Walter U. NO at work. Cell 1994; 78:919-925.
31. 31 Dinarello C, Wolff S. The role of IL-1 in disease. N Engl J Med 1993; 328:106-113.
32. 32 Dinarello C. The interleukin-1 family: 10 years of discovery. FASEB J 1994; 8:1314-1325.
33. 33 Vannier E, Miller L, Danarello C. Co-ordinated anti-inflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but upregulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992; 89:4076-4080.
34. 34 Casini-Raggi V, Kam L, Chong Y, Fiocchi C, Pizarro T, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immunol 1995; 154:2434-2440.
35. 35 Mansfield J, Holden H, Tarlow J, Di Giovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106:637-642.
36. 36 Geller D, DeVera M, Russell D, et al. A central role for IL-1β in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. J Immunol 1995; 155:4890-4898.
37. 37 Kontakou M, Przemioslo R, Sturgess R, Limb A, Ciclitira P. Expression of tumour necrosis factor-α, interleukin-6 and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand J Gastroenterol 1995; 30:456-463.
38. 38 Przemioslo R, Kontakou M, Nobili V, Ciclitira P. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor α in coeliac disease mucosa detected by immunohistochemistry. Gut 1994; 35:1398-1404.